Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TFF1 anticorps (AA 57-84)

TFF1 Reactivité: Humain, Cynomolgus IF, FACS, IHC (p) Hôte: Souris Monoclonal SPM313 unconjugated
N° du produit ABIN6251840
  • Antigène Voir toutes TFF1 Anticorps
    TFF1 (Trefoil Factor 1 (TFF1))
    Épitope
    • 27
    • 15
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 57-84
    Reactivité
    • 81
    • 18
    • 16
    • 13
    • 9
    Humain, Cynomolgus
    Hôte
    • 45
    • 43
    • 1
    Souris
    Clonalité
    • 47
    • 42
    Monoclonal
    Conjugué
    • 56
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp TFF1 est non-conjugé
    Application
    • 44
    • 35
    • 34
    • 29
    • 20
    • 13
    • 6
    • 6
    • 6
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Protein G affinity chromatography
    Immunogène
    Amino acids CFDDTVRGVPWCFYPNTIDVPPEEECEF (aa57-84) from the human protein were used as the immunogen for the Estrogen Inducible Protein pS2 antibody.
    Clone
    SPM313
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product TFF1 Anticorps primaire
  • Indications d'application
    Flow Cytometry: 0.5-1 μg/million cells in 0.1ml

    Immunofluorescence: 0.5-1 μg/mL

    Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)

    Prediluted format: incubate for 30 min at RT (2)

    Optimal dilution of the Estrogen Inducible Protein pS2 antibody should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.2 mg/mL
    Buffer
    PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Aliquot and Store at -20C. Avoid freez-thaw cycles.
  • Antigène
    TFF1 (Trefoil Factor 1 (TFF1))
    Autre désignation
    Estrogen Inducible Protein pS2 (TFF1 Produits)
    Synonymes
    anticorps BCEI, anticorps D21S21, anticorps HP1.A, anticorps HPS2, anticorps pNR-2, anticorps pS2, anticorps Bcei, anticorps PS2, anticorps bcei, anticorps d21s21, anticorps hp1.a, anticorps hps2, anticorps p1, anticorps p1-a, anticorps pnr-2, anticorps ps2, anticorps tff1, anticorps xP1, anticorps xp1-L, anticorps xp1, anticorps TFF1, anticorps Ps2, anticorps trefoil factor 1, anticorps trefoil factor 1 S homeolog, anticorps trefoil factor 1, gene 2 S homeolog, anticorps TFF1, anticorps Tff1, anticorps tff1.S, anticorps tff1.2.S, anticorps LOC100358238
    Sujet
    It recognizes a polypeptide of 6.5  kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60 % of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy.
    ID gène
    7031
    UniProt
    P04155
    Pathways
    EGFR Signaling Pathway
Vous êtes ici:
Support technique